New drug duo aims to keep advanced breast cancer in check
NCT ID NCT02942355
Summary
This study is testing the safety and feasibility of using two drugs, anastrozole and palbociclib, together to control advanced breast cancer that has spread. It is for postmenopausal women whose cancer is hormone-sensitive and HER2-negative. The trial has two groups: one testing the drugs as a first treatment, and another testing them as a maintenance therapy after initial chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
Conditions
Explore the condition pages connected to this study.